Literature DB >> 9120177

Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake.

K Kario1, T Matsuo, H Kobayashi, K Yamamoto, K Shimada.   

Abstract

OBJECTIVES: We sought to investigate the potentiation of acute risk factors after the Hanshin-Awaji earthquake (7.2 on the Richter scale).
BACKGROUND: The frequency of cardiovascular events increases just after a major earthquake, but the causative factors have not been fully investigated.
METHODS: We studied the changes in cardiovascular risk factors in 42 elderly outpatients with well-controlled hypertension living near the epicenter (Awaji-Hokudan districts) 7 to 14 days after the earthquake when the major felt-aftershocks persisted. They all experienced the highest stress grading of 6 (catastrophic stress) according to the DSM-III-R. To study the hemostatic profile and endothelial cell state, we measured the blood pressure (BP), hematocrit and lipid profiles as well as fibrinogen, a marker of fibrin turnover (D-dimer), fibrinolytic factors (plasmin-alpha2-plasmin inhibitor complex [PIC], tissue-type plasminogen activator [t-PA] antigen and t-PA inhibitor [PAI] activity) and an endothelial cell-derived marker (von Willebrand factor [vWF]).
RESULTS: Systolic and diastolic blood pressures and other variables increased after the earthquake. Before and after the earthquake, the median (25th to 75th percentiles) systolic BP was 152 (range 142 to 164) and 170 mm Hg (range 161 to 178), respectively (p < 0.0001), and the diastolic BP was 83 (range 79 to 88) and 91 mm Hg (range 84 to 96), respectively (p < 0.0001). Of blood viscosity determinants, hematocrit was 38.1% (range 40.7% to 35.9%) and 39.7% (range 42.9% to 38.3%), respectively (p < 0.001), and fibrinogen 316 (range 272 to 360) and 335 mg/dl (range 307 to 391), respectively (p < 0.05). Von Willebrand factor was 128% (range 74% to 148%) and 148% (range 100% to 178%), respectively (p < 0.01); D-dimer was 410 (range 285 to 633) and 560 ng/ml (range 391 to 888), respectively (p < 0.0001); and PIC was 0.74 (range 0.58 to 0.91) and 0.75 microg/ml (range 0.58 to 1.1), respectively (p < 0.05). In contrast, lipid profiles did not change after the quake. When the patients were classified into the high stress and moderate stress groups according to the degrees of damage to their house and injury to family members, the levels of fibrinogen, vWF, PIC and t-PA antigen were increased only in the former group, whereas BP, hematocrit and D-dimer levels were increased in both groups. These abnormalities of acute risk factors, except for vWF, were transient and decreased to prequake levels by 4 to 6 months after the quake.
CONCLUSIONS: Earthquake-induced stress seems to induce transient increases in BP, blood viscosity determinants and fibrin turnover and to prolong endothelial cell stimulation. The potentiation of these acute risk factors might contribute to the occurrence of cardiovascular events just after a major earthquake in elderly subjects with hypertension.

Entities:  

Mesh:

Year:  1997        PMID: 9120177     DOI: 10.1016/s0735-1097(97)00002-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

Review 1.  Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease.

Authors:  Roland von Känel; Joel E Dimsdale
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

Review 2.  Mental stress as a causal factor in the development of hypertension and cardiovascular disease.

Authors:  T G Pickering
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  The impact of the Chi-Chi earthquake on quality of life among elderly survivors in Taiwan--a before and after study.

Authors:  Mau-Roung Lin; Wenzheng Huang; Chingchaw Huang; Hei-Fen Hwang; Lung-Wen Tsai; Yun-Ning Chiu
Journal:  Qual Life Res       Date:  2002-06       Impact factor: 4.147

4.  Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?

Authors:  Daniel Preckel; Roland von Känel
Journal:  Heartdrug       Date:  2004

5.  Observational study of 1-year mortality rates before and after a major earthquake among Chinese nonagenarians.

Authors:  Joseph H Flaherty; Birong Dong; Hongmei Wu; Yanling Zhang; Jack M Guralnik; Theodore K Malmstrom; John E Morley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-10       Impact factor: 6.053

Review 6.  Disaster hypertension: experience from the great East Japan earthquake of 2011.

Authors:  Masafumi Nishizawa; Satoshi Hoshide; Masahisa Shimpo; Kazuomi Kario
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

7.  Relationship between the degree of property damage and changes in red blood cells, hematocrit, and hemoglobin among victims of the Noto Peninsula Earthquake.

Authors:  Shizuko Omote; Miho Kato; Teruhiko Kido; Rie Okamoto; Akie Ichimori; Chiaki Sakakibara; Keiko Tsukasaki
Journal:  Environ Health Prev Med       Date:  2012-11-07       Impact factor: 3.674

8.  Acute changes in home blood pressure after the Great East Japan Earthquake among patients with chronic kidney disease in Fukushima City.

Authors:  Kimio Watanabe; Yoshihiro Tani; Kenichi Tanaka; Yoshimitsu Hayashi; Koichi Asahi; Masaaki Nakayama; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2012-12-06       Impact factor: 2.801

9.  Pathophysiological processes underlying emotional triggering of acute cardiac events.

Authors:  Philip C Strike; Kesson Magid; Daisy L Whitehead; Lena Brydon; Mimi R Bhattacharyya; Andrew Steptoe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-02       Impact factor: 11.205

10.  Increased risk of acute myocardial infarction after the Great East Japan Earthquake.

Authors:  Akihiro Nakamura; Eiji Nozaki; Shigefumi Fukui; Hideaki Endo; Tohru Takahashi; Kenji Tamaki
Journal:  Heart Vessels       Date:  2013-04-20       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.